Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

158.27 +1.96 (+1.25%)
Streaming Delayed Price Updated: 2:19 PM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,725,933
Open 156.65
Bid (Size) 158.25 (2)
Ask (Size) 158.30 (4)
Prev. Close 156.31
Today's Range 156.20 - 158.52
52wk Range 130.96 - 182.89
Shares Outstanding N/A
Dividend Yield 3.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend Stocks to Double Up on Right Now
The stories for these great dividend stocks are better than many might think. 
Via The Motley Fool

Performance

YTD
-0.97%
-0.97%
1 Month
-5.68%
-5.68%
3 Month
-11.13%
-11.13%
6 Month
+14.13%
+14.13%
1 Year
+14.18%
+14.18%

More News

Read More
7 Biotech Stocks to Put on Your Breakthrough Radar
Via InvestorPlace
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Via The Motley Fool
Evolus: Chiseling Away At The Aesthetic Market
Via Talk Markets
This Is What Whales Are Betting On AbbVie
Via Benzinga
A Must-Own Stock for Any Portfolio
Via The Motley Fool
2 Billion More Reasons to Buy AbbVie Stock
Via The Motley Fool
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
Via Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Via Benzinga
Topics Data Breach
Exposures Information Security
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
Via FinancialNewsMedia
Topics Death
Exposures Death
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Via Benzinga
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
From FN Media Group LLC
Via GlobeNewswire
3 Biotech Stocks to Buy on the Dip: May 2024
Via InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
Via InvestorPlace
7 Safe-Haven Stocks to Weather Any Storm
Via InvestorPlace
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
Via InvestorPlace
Topics Stocks
Exposures US Equities
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
10 Stocks to Build a Dividend Portfolio With
Via The Motley Fool
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Via Benzinga
7 Value Stocks to Buy and Hold for a Decade of Dominance
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.